50 results on '"Moulinet, Thomas"'
Search Results
2. When and which second-line workup to perform for uveitis: a tertiary care center experience
3. The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy
4. Successful treatment of JAK1-associated inflammatory disease
5. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
6. JAK inhibitors and systemic sclerosis: A systematic review of the literature
7. Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature
8. Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up
9. LBP2 Development and validation of a patient-centered autoevaluation questionnaire in systemic lupus erythematosus: LUPIN
10. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
11. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
12. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France
13. Thrombotic Thrombocytopenic Purpura Without Schistocytes: Beware of Misdiagnosis
14. The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy
15. Diagnoses associated with temporal arteritis
16. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.
17. Challenging diagnosis of granulomatosis after switching mepolizumab by dupilumab for severe asthma
18. ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
19. Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies
20. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome
21. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
22. Anti-TNF-α versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network
23. Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study
24. Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients
25. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome.
26. Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema
27. Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
28. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis
29. Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study.
30. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
31. Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia
32. Serious Infections in Patients with Vexas Syndrome: A Study from the French Vexas Group
33. Whole Exome Sequencing of Patients with Adult-Onset Evans Syndrome: A Cohort of 80 Patients
34. Maladie de Behçet : description et analyse d’une série rétrospective monocentrique française de 51 patients
35. Giant cell arteritis-related aortic dissection: A multicenter retrospective study
36. Clinical characteristics, management and outcome of COVID‐19‐associated immune thrombocytopenia: a French multicentre series
37. Corrigendum to “Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis” [AUTREV 18–11 (2019) 102395]
38. Cutaneous manifestations of lymphoid‐variant hypereosinophilic syndrome.
39. Evaluation of innate lymphoid cells, mucosal-associated invariant T cells and helper T cells in human autoimmune uveitis
40. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis
41. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia
42. Intractable anemia due to extensive refractory angiodysplasia of the small intestine stabilized by an anti-angiogenic agent
43. Successful treatment with thrombolysis and stent in acute limb ischemia complicating antiphospholipid syndrome
44. Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry
45. Evaluation of innate lymphoid cells, mucosal-associated invariant T cells and helper T cells in human autoimmune uveitis
46. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
47. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
48. ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome.
49. [Behçet's disease : Description and analysis of a French single-center retrospective study of 51 patients].
50. Intractable anemia due to extensive refractory angiodysplasia of the small intestine stabilized by an anti-angiogenic agent.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.